Life science stocks are under pressure due to possible NIH funding cuts. What lies ahead for the sector
Related
Healthy Returns: RFK Jr.’s Covid vaccine recommendation chan...
1 month ago
180
UnitedHealth Group shares plunge 18% on reported DOJ probe i...
1 month ago
223
Kennedy sidesteps vaccine questions: ‘I don’t think people s...
1 month ago
194
Hims & Hers gives weak outlook but says more collaborations ...
1 month ago
266
Eli Lilly sales soar 45% on weight loss drug demand, but dru...
2 months ago
201
Oracle engineers caused days-long software outage at U.S. ho...
2 months ago
202
23andMe bankruptcy: With America's DNA put on sale, market p...
3 months ago
262
Bristol Myers' stock decline in response to weak guidance is...
4 months ago
247
Eli Lilly posts mixed quarter even as demand for weight loss...
4 months ago
208
23andMe is exploring strategic alternatives, looking to rais...
5 months ago
228
We're lightening up on a rallying stock that's grown too big...
5 months ago
210
Our newest portfolio stock backed off its recent 52-week hig...
6 months ago
243
Prostavive Reviews: Top Benefits, Natural Solution and How P...
7 months ago
747
Trump says RFK Jr. plan to remove fluoride from public water...
7 months ago
249
CVS to replace CEO Karen Lynch with exec David Joyner as pro...
8 months ago
275
This government-backed startup is growing blood to help figh...
9 months ago
282
4 ways how cancer care has improved in India
1 year ago
401
Trending
Popular
'Razor Blade throat in Covid 19:' Why does it hurt so much
5 days ago
462
Who is Shefali Jariwala's husband Parag Tyagi?
5 days ago
433
BTS' V to appear in ‘Squid Game Season 3’?
6 days ago
363
Squid Game 3: When and where to watch in India
6 days ago
236
'Kannappa' set to cross Rs 20 crore on first weekend
4 days ago
186
© Rclipse.Com 2025. All rights are reserved